-
SILINTAN may be harmful due to hidden drug ingredient
23 Sep 2025 15:12 GMT
… product label.
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID). NSAIDs … . This hidden drug ingredient may also interact with other medications and significantly … caution before purchasing these products.
FDA is unable to test and …
-
Harnessing Cationic Bilosomes to Create a Green Light-Triggered Nanoplatform for Skin Melanoma Treatment
22 Sep 2025 13:16 GMT
… of treatment in the selected medical fields. These drug … drug release and drug loading in liposomes. Cells Nanomed Biotechnol … for market approval as pharmaceutical products: analytical methods … transdermal delivery of meloxicam and ketoprofen: optimization …
-
Nanocrystalline Drug Delivery Systems for Natural Compounds: Progress, Challenges and Future Opportunities
17 Sep 2025 17:46 GMT
… remedies in the realm of drug development.6
Despite their considerable medicinal … products: a review. Biotechnol Adv. 2015;33( … for the treatment of bronchopulmonary aspergillosis. … polysaccharide nanocrystals as pharmaceutical excipients. Carbohydr Polym. …
-
Viatris Inc. (VTRS) Enters $515M IV Iron Market With FDA Green Light
17 Sep 2025 21:38 GMT
… pharmaceuticals. Operating in over 165 countries, the company blends established medicines … in 2025 is the FDA approval of Viatris Inc … trial results for several pipeline assets, including fast-acting meloxicam … IV Iron Market With FDA Green Light Viatris Inc. …
-
Veterinary Pharmaceutical Solutions expands into poultry sector
14 Sep 2025 22:22 GMT
… (VPS), a leader in livestock pharmaceutical compounding, announces its formal expansion … time recommendations for Meloxicam and ibuprofen—currently the only FDA-legal water … delivering high-quality, customized compounded medications,” said Stacy Peters, Chief …
-
Hydrogel-Based Microspheres for Intra-Articular Osteoarthritis Therapy: Multifunctional Carriers for Drug Delivery and Cartilage Repair: A Comprehensive Review
03 Sep 2025 20:34 GMT
… drug delivery for intra-articular treatment of osteoarthritis.32 Additionally, meloxicam … , few clinical trials or translational studies … Drug Retention in Knees after Intra-Articular Injection. Pharmaceutics … Chondrocytes. Front Bioeng Biotechnol. 2021;9. …
-
Unichem Pharmaceuticals recalls mislabeled Cyclobenzaprine tablets in US over safety concerns
03 Sep 2025 09:13 GMT
… Meloxicam 7.5 mg tablets, a non-steroidal anti-inflammatory drug … US Food and Drug Administration (FDA). Consumers experiencing … quality checks in pharmaceutical packaging and labeling, … mislabeling in prescription medications.
Aditya Bhagchandani serves …
-
Recall: The label says muscle relaxer, but arthritis drugs are in the bottle
03 Sep 2025 05:30 GMT
… Pharmaceuticals has recalled one lot of a muscle relaxer because the pills … Brunswick, New Jersey, company’s FDA-posted recall notice says the … Meloxicam 7.5 mg tablets. Meloxicam is a non-steroidal anti-inflammatory drug …
-
Former UI soccer player accuses UIHC of medical negligence
01 Sep 2025 10:44 GMT
… of negligence in their treatment of an ankle injury … of platelets, steroids, and meloxicam.
“But she never fully … ankle specialist at Northwestern Medicine who told her Duchman … talus.
In accusing UIHC of medical negligence; negligent hiring, training, …
-
Unichem Pharmaceuticals (USA) Inc. Issues Voluntary Nationwide Recall of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, Due to Mislabeling
27 Aug 2025 21:33 GMT
…
FDA Publish Date:
August 27, 2025
Product Type:
Drugs
… Meloxicam, or those with underlying illness. To date, Unichem Pharmaceuticals … not further distribute, this medication, and notify their customers … should return the medication to the pharmacy they …